Literature DB >> 20975619

Are genetic variants of COMT associated with addiction?

Anne Emilia Tammimäki1, Pekka T Männistö.   

Abstract

The human catechol-O-methyl transferase (COMT) gene contains multiple single-nucleotide polymorphisms, some of which are postulated to have clinical significance. This article reviews human studies that have explored the association between COMT polymorphisms and addiction to drugs, alcohol or tobacco. Most studies concentrate on the Val108/158Met polymorphism. Although there are reports indicating a positive association with COMT polymorphisms and addiction, the majority of the studies failed to detect such a link between them with one exception, smoking. It is unlikely that there would be any single gene that could be designated as 'the addiction gene'. Rather, there seems to be a great number of genes that are associated with addiction, among which COMT seems to have a minor role. Environmental factors and genetic milieu have a great impact on whether the small effects of COMT polymorphisms on risk of addiction can be detected in a given population. Sex differences complicate the gene-environment interplay even further.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20975619     DOI: 10.1097/FPC.0b013e328340bdf2

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  25 in total

1.  Impact of COMT Val158Met-polymorphism on appetitive conditioning and amygdala/prefrontal effective connectivity.

Authors:  Tim Klucken; Onno Kruse; Sina Wehrum-Osinsky; Juergen Hennig; Jan Schweckendiek; Rudolf Stark
Journal:  Hum Brain Mapp       Date:  2014-11-13       Impact factor: 5.038

2.  The genetic basis of addictive disorders.

Authors:  Francesca Ducci; David Goldman
Journal:  Psychiatr Clin North Am       Date:  2012-06

3.  Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.

Authors:  Orna Levran; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Ann Hum Genet       Date:  2015-02-27       Impact factor: 1.670

4.  Differential COMT expression and behavioral effects of COMT inhibition in male and female Wistar and alcohol preferring rats.

Authors:  Aqilah M McCane; Michael J DeLory; Maureen M Timm; Sarine S Janetsian-Fritz; Christopher C Lapish; Cristine L Czachowski
Journal:  Alcohol       Date:  2017-08-19       Impact factor: 2.405

5.  Catehol-o-methyltransferase gene Val158met polymorphism as a potential predictor of response to computer-assisted delivery of cognitive-behavioral therapy among cocaine-dependent individuals: Preliminary findings from a randomized controlled trial.

Authors:  Kathleen M Carroll; Aryeh Herman; Elise E DeVito; Tami L Frankforter; Marc N Potenza; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2015-05-01

Review 6.  Epigenetic and Neural Circuitry Landscape of Psychotherapeutic Interventions.

Authors:  Christopher W T Miller
Journal:  Psychiatry J       Date:  2017-05-25

7.  Association of abstinence-induced alterations in working memory function and COMT genotype in smokers.

Authors:  Rebecca L Ashare; Jeffrey N Valdez; Kosha Ruparel; Benjamin Albelda; Ryan D Hopson; John R Keefe; James Loughead; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2013-07-05       Impact factor: 4.530

Review 8.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

Review 9.  Overview of the Genetics of Alcohol Use Disorder.

Authors:  Elisabeth A Tawa; Samuel D Hall; Falk W Lohoff
Journal:  Alcohol Alcohol       Date:  2016-07-21       Impact factor: 2.826

Review 10.  Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity.

Authors:  Maiqiu Wang; Yunlong Ma; Wenji Yuan; Kunkai Su; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2016-01-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.